Preparation and evaluation of [99mTc]DEPE as a cardiac perfusion agent.
Technetium-99m labeled bis(1,2-diethylphosphino)ethane was evaluated as a cardiac perfusion agent in mice, dogs and normal human volunteers. The agent produced as a single cationic compound was prepared by a simple kit type method and had a rapid myocardial uptake in animals. The cardiac uptake of the agent in dogs averaged 4.6% of administered dose and delineated left and right ventricles by in vivo imaging. In dogs with experimental myocardial infarction, the agent was distributed according to the regional myocardial blood flow, had excellent correlation with myocardial distribution of 85Sr microspheres (r = 0.96, 0.93)] and 201Tl (r = 0.91 and 0.83), and enabled us to detect perfusion defects by in vivo scintigraphy. The agent, however, failed to have a useful degree of cardiac uptake in humans.
D000818:Animals; D004285:Dogs; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D051379:Mice; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D009943:Organophosphorus Compounds / Q000378:metabolism; D015609:Organotechnetium Compounds; D010720:Phosphines; D011877:Radionuclide Imaging; D013667:Technetium / Q000378:metabolism; D014018:Tissue Distribution
D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D010720:Phosphines; C041972:technetium Tc 99m-bis(1,2-diethylphosphino)ethane; D013667:Technetium